Skip to Content

MYLAN 5300 MYLAN 5300 (Nizatidine 300 mg)

Pill with imprint MYLAN 5300 MYLAN 5300 is Purple, Capsule-shape and has been identified as Nizatidine 300 mg. It is supplied by Mylan Pharmaceuticals Inc..

Nizatidine is used in the treatment of gerd; erosive esophagitis; stomach ulcer; indigestion; duodenal ulcer and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 5300 MYLAN 5300

Nizatidine 300 mg MYLAN 5300 MYLAN 5300
Nizatidine 300 mg MYLAN 5300 MYLAN 5300 Front
Nizatidine 300 mg MYLAN 5300 MYLAN 5300 Back
Nizatidine 300 mg MYLAN 5300 MYLAN 5300
Nizatidine 300 mg MYLAN 5300 MYLAN 5300

Nizatidine

Imprint
MYLAN 5300 MYLAN 5300
Strength
300 mg
Color
Purple
Size
17.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-5300
Inactive Ingredients
ammonia, lactose anhydrous, silicon dioxide, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin, isopropyl alcohol, magnesium stearate, butyl alcohol, corn starch, propylene glycol, shellac, dimethicone, sodium lauryl sulfate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.